Contact Us
INNOGLY INNOGLY INNOGLY INNOGLY
Navigation
  • About us
    • COST Action
    • Network members
    • Scientific Outputs
      • Scientific Publications
      • Abstracts from Events
  • News
  • Events
  • Working Groups
    • Development and Cancer
    • Autophagy
    • Immunity
    • GAGs
  • STSM
    • STSM information
    • STSM proposal
    • STSM evaluation
    • Awarded STSMs
  • ITC Grants
  • Training Schools

Logged out

Lost Password?

News

Call for Short Term Scientific Missions (STSMs) 2021
The 1st and the only call for the Short Term ...
Read More
WG1-WG3 Joint Meeting “Glycosylation in Cancer and Tumour Immunology”
Dates: 8th and 9th October 2020 i3S – Instituto de Investigação ...
Read More
INNOGLY Virtual Training in GlycoAnalysis and GlycoInformatics 2nd-3rd of November 2020
Here the Final PDF: https://drive.google.com/file/d/1tF1RbLH_4y3-DzTccLjct8kWgyIqXomO/view?usp=sharing Monday- GlycoAnalysisCentral European Time (CET) 2-Nov 10-10.45 ...
Read More
WG1 & WG3 Joint Meeting “Glycosylation in Cancer and Tumour Immunology”
COST Action CA18103 INNOGLY: INNOvation with Glycans new frontiers from ...
Read More
Assistant Professor of Biological Neurochemistry (Tenure Track)
Our INNOGLY members are looking for... Biological neurochemistry is at the ...
Read More

WG1-WG3 Joint Meeting “Glycosylation in Cancer and Tumour Immunology”

Dates: 8th and 9th October 2020
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto,
Porto, Portugal and Virtual Conference
Organizers:
Ana Magalhães
Barbara Richichi
Celso A. Reis
Programme:
Indicated times are Western European Summer Time (West Time).
8th October (Thursday)
14h00-14h30 – Registration
14h30-14h45 – Welcome Session (Barbara Richichi and Celso A. Reis)
> Session I
Chair: Celso A. Reis
14h45-15h05 – Keynote lecture KL1-Robert Sackstein (15+5 min) – Glycan Determinants in Cancer as Targets for CAR-T-cell-based Therapeutics
15h05-15h25 – Keynote lecture KL2-Sandra van Vliet (15+5 min) – FUT9-Driven Programming of Colon Cancer Cells Towards a Stem Cell-Like State
15h25-15h55 –Selected Communications
SC1 – José Reina Martin (8+2 min) – Selectins Ligands to Target Endothelial Cells Surrounding Metastatic Tumors
SC2 – Kristina A. Thomsson (8+2 min) – O-glycan sulfation on ovarian cancer cyst fluid mucin-type proteins
SC3 – Tomasz Kobiela (8+2 min) – Characterization of cell-surface glycans interactions with lectins as test for melanoma development
16h00 – 16h30 – Coffee-Break
16h30-19h00 – MC Meeting (Chair: Luigi Lay)
9th October (Friday)
> Session II
Chair: Ana Magalhães
9h15-9h35 – Keynote lecture KL3 – Bernadette Tse Sum Bui (15+5 min) – Molecularly Imprinted Polymers: Chemical Antibody Mimics for Clinical Diagnosis and Therapy
9h35-9h55 – Keynote lecture KL4 – Niclas Karlsson (15+5 min) – Gastric O-glycomic discovery is revealing surprises regarding H. pylori interaction
9h55-10h20 – Selected Communications
SC4 – Angelina Palma (8+2 min) – Sialyl ligands other than the α2,6-sialyl-Tn O-glycan identified for human Siglec-15
SC5 – Dragana Nikitovic (8+2 min) – Lumican stimulates chondrosarcoma cell growth by regulating IGF-IR activity
10h30 – 11h00 – Coffee-Break
> Session III
Chair: Barbara Richichi
11h00-11h20 – Keynote lecture KL5- Anne Harduin-Lepers (15+5 min) – B4GALNT2 controls Sda and sLex antigens biosynthesis in healthy and cancer human colon
11h20-11h40 – Keynote lecture KL6 –Ramon Hurtado Guerrero (15+5 min) – Structural basis for substrate specificity and catalysis of α1,6-fucosyltransferase
11h40-12h10 – Selected Communications
SC6 – Fumiichiro Yamamoto (8+2 min) – ABO Blood Groups in Immunology and Cancer
SC7 – Matjaz Weiss (8+2 min) – In vitro modulation of protein O-GlcNAcylation and its impact on dendritic cells function
12h10- 12h30 – Keynote lecturer KL7- Ruben Ragg (15+5 min) – Getting Published in 2020 and Beyond: How to Adapt to a Rapidly Changing Publication Landscape
12h30 – 12h50 – Closing session (Barbara Richichi, Celso A. Reis, Luigi Lay)

October 7, 2020

Events

WG1-WG3 Joint Meeting “Glycosylation in Cancer and Tumour Immunology”
Dates: 8th and 9th October 2020 i3S – Instituto de Investigação ...
Read More
INNOGLY Virtual Training in GlycoAnalysis and GlycoInformatics 2nd-3rd of November 2020
Here the Final PDF: https://drive.google.com/file/d/1tF1RbLH_4y3-DzTccLjct8kWgyIqXomO/view?usp=sharing Monday- GlycoAnalysisCentral European Time (CET) 2-Nov 10-10.45 ...
Read More
WG1 & WG3 Joint Meeting “Glycosylation in Cancer and Tumour Immunology”
COST Action CA18103 INNOGLY: INNOvation with Glycans new frontiers from ...
Read More

Follow us on Twitter


Follow INNOGLY

Twitter Timeline

RT @Rob_Field_Lab: GLYTUNES: Call for applications for Early Stage Researchers for 14 Doctoral (PhD) Training Positions in Glycosciences an…

RT @FabrizioChiodo: Wow! @Dereklowe teaching some Glycoscience!!! Thanks #glycotime

RT @AlbaSilipo: MSCA ITN-ETN GLYTUNES: Call for applications for Early Stage Researchers for 14 Doctoral (PhD) Training Positions in Glycos…

RT @FabrizioChiodo: We are hiring! Are you interested in Glyco-Immunology at the Host-Pathogens Interface? We have 14 available PhD positio…

RT @peterseeberger: Anti-carbohydrate antibodies in #multiplesclerosis patients with specificity for a bacterial epitope detected by glycan…

POLICY STATEMENT:

Biomedicine and Molecular Biosciences Action CA18103 is funded by COST, which is supported by the EU Framework Programme Horizon 2020.

COST Action CA18103

© Copyright 2021. All Rights Reserved | Powered by innogly.eu | Designed by AWA
  • Imprint
  • /
  • Privacy policy
  • /

Cookies

This site uses cookies: Find out more.